Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
DESTINY-Lung01, a phase II trial evaluating the efficacy of T-DXd in pre-treated NSCLC harboring HER2 molecular alterations includes two cohorts of patients: The HER2 -mutant cohort included 91 patients, showing an ORR of 55%, a median DoR of 9.3 months (95% CI, 5.7 to 14.7) and medians PFS and OS of 8.2 (95% CI, 6.0 to 11.9) and 17.8 months (95% CI, 13.8 to 22.1), respectively [4,33,34]
Check Whether Vitamin C Is Included Vitamin C helps maintain glutathione in an active form as well as the synthesis of collagen
While minor rolling is fine, aggressive shaking should be avoided
A digital COA is available on request
US$ 21.53
US$ 29.35
US$ 21.32
US$ 24.53
US$ 21.36
US$ 21.61
US$ 26.00
US$ 23.97
US$ 29.44
US$ 25.94
US$ 29.28
